FORTREA HOLDINGS INC (FTRE) Stock Fundamental Analysis
USA - NASDAQ:FTRE - US34965K1079 - Common Stock
10.46 USD
+0.43 (+4.29%)
10.46 USD
0 (0%)
Overall FTRE gets a fundamental rating of 2 out of 10. We evaluated FTRE against 58 industry peers in the Life Sciences Tools & Services industry. FTRE may be in some trouble as it scores bad on both profitability and health. FTRE has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
FTRE had positive earnings in the past year.
In the past year FTRE has reported a negative cash flow from operations.
In multiple years FTRE reported negative net income over the last 5 years.
FTRE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of FTRE (-36.22%) is worse than 79.31% of its industry peers.
FTRE's Return On Equity of -174.29% is on the low side compared to the rest of the industry. FTRE is outperformed by 86.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.22% | ||
| ROE | -174.29% | ||
| ROIC | N/A |
ROA(3y)-1.75%
ROA(5y)-2.26%
ROE(3y)-6.6%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 19.73%, FTRE is not doing good in the industry: 82.76% of the companies in the same industry are doing better.
FTRE's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for FTRE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5YN/A
2. Health
2.1 Basic Checks
FTRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FTRE has been increased compared to 1 year ago.
The debt/assets ratio for FTRE has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.48, we must say that FTRE is in the distress zone and has some risk of bankruptcy.
FTRE has a worse Altman-Z score (0.48) than 70.69% of its industry peers.
FTRE has a Debt/Equity ratio of 1.87. This is a high value indicating a heavy dependency on external financing.
FTRE has a worse Debt to Equity ratio (1.87) than 82.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.48 |
ROIC/WACCN/A
WACC10.22%
2.3 Liquidity
FTRE has a Current Ratio of 1.02. This is a normal value and indicates that FTRE is financially healthy and should not expect problems in meeting its short term obligations.
FTRE has a Current ratio of 1.02. This is amonst the worse of the industry: FTRE underperforms 87.93% of its industry peers.
A Quick Ratio of 1.02 indicates that FTRE should not have too much problems paying its short term obligations.
FTRE has a worse Quick ratio (1.02) than 79.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 1.02 |
3. Growth
3.1 Past
FTRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.22%, which is quite impressive.
The Revenue has decreased by -4.96% in the past year.
The Revenue has been decreasing by -4.10% on average over the past years.
EPS 1Y (TTM)72.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%733.33%
Revenue 1Y (TTM)-4.96%
Revenue growth 3Y-4.1%
Revenue growth 5YN/A
Sales Q2Q%7.23%
3.2 Future
FTRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.26% yearly.
Based on estimates for the next years, FTRE will show a small growth in Revenue. The Revenue will grow by 1.53% on average per year.
EPS Next Y66.4%
EPS Next 2Y58.23%
EPS Next 3Y50.63%
EPS Next 5Y42.26%
Revenue Next Year-2.39%
Revenue Next 2Y-1.42%
Revenue Next 3Y-0.01%
Revenue Next 5Y1.53%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
FTRE is valuated correctly with a Price/Earnings ratio of 16.87.
Based on the Price/Earnings ratio, FTRE is valued cheaply inside the industry as 93.10% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.11, FTRE is valued a bit cheaper.
With a Price/Forward Earnings ratio of 12.29, FTRE is valued correctly.
FTRE's Price/Forward Earnings ratio is rather cheap when compared to the industry. FTRE is cheaper than 94.83% of the companies in the same industry.
FTRE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.55.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.87 | ||
| Fwd PE | 12.29 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FTRE is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 249.3 |
4.3 Compensation for Growth
FTRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FTRE's earnings are expected to grow with 50.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y58.23%
EPS Next 3Y50.63%
5. Dividend
5.1 Amount
FTRE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.46
+0.43 (+4.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners112.28%
Inst Owner Change-0.42%
Ins Owners0.34%
Ins Owner Change31.69%
Market Cap949.77M
Revenue(TTM)2.73B
Net Income(TTM)-1026900000
Analysts53.75
Price Target8.77 (-16.16%)
Short Float %10.9%
Short Ratio6.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)162.11%
Min EPS beat(2)126.66%
Max EPS beat(2)197.56%
EPS beat(4)2
Avg EPS beat(4)65.68%
Min EPS beat(4)-51.68%
Max EPS beat(4)197.56%
EPS beat(8)3
Avg EPS beat(8)-57.12%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.8%
Min Revenue beat(2)4.96%
Max Revenue beat(2)10.63%
Revenue beat(4)2
Avg Revenue beat(4)2.7%
Min Revenue beat(4)-2.83%
Max Revenue beat(4)10.63%
Revenue beat(8)3
Avg Revenue beat(8)-1.24%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.42%
PT rev (3m)43.93%
EPS NQ rev (1m)7.55%
EPS NQ rev (3m)9.57%
EPS NY rev (1m)0.18%
EPS NY rev (3m)18.07%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)5.94%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)4.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.87 | ||
| Fwd PE | 12.29 | ||
| P/S | 0.35 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 249.3 |
EPS(TTM)0.62
EY5.93%
EPS(NY)0.85
Fwd EY8.14%
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-0.97
OCFYN/A
SpS30.1
BVpS6.49
TBVpS-11.35
PEG (NY)0.25
PEG (5Y)N/A
Graham Number9.51
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.22% | ||
| ROE | -174.29% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.73% | ||
| FCFM | N/A |
ROA(3y)-1.75%
ROA(5y)-2.26%
ROE(3y)-6.6%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5YN/A
F-Score3
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 134.26 | ||
| Cap/Depr | 18.99% | ||
| Cap/Sales | 0.56% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.02 | ||
| Quick Ratio | 1.02 | ||
| Altman-Z | 0.48 |
F-Score3
WACC10.22%
ROIC/WACCN/A
Cap/Depr(3y)43.05%
Cap/Depr(5y)33.05%
Cap/Sales(3y)1.37%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%733.33%
EPS Next Y66.4%
EPS Next 2Y58.23%
EPS Next 3Y50.63%
EPS Next 5Y42.26%
Revenue 1Y (TTM)-4.96%
Revenue growth 3Y-4.1%
Revenue growth 5YN/A
Sales Q2Q%7.23%
Revenue Next Year-2.39%
Revenue Next 2Y-1.42%
Revenue Next 3Y-0.01%
Revenue Next 5Y1.53%
EBIT growth 1Y-39.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-41.82%
EBIT Next 3Y10.43%
EBIT Next 5Y11.67%
FCF growth 1Y85.25%
FCF growth 3Y18.31%
FCF growth 5YN/A
OCF growth 1Y56.06%
OCF growth 3Y15.67%
OCF growth 5YN/A
FORTREA HOLDINGS INC / FTRE FAQ
What is the ChartMill fundamental rating of FORTREA HOLDINGS INC (FTRE) stock?
ChartMill assigns a fundamental rating of 2 / 10 to FTRE.
What is the valuation status of FORTREA HOLDINGS INC (FTRE) stock?
ChartMill assigns a valuation rating of 5 / 10 to FORTREA HOLDINGS INC (FTRE). This can be considered as Fairly Valued.
What is the profitability of FTRE stock?
FORTREA HOLDINGS INC (FTRE) has a profitability rating of 2 / 10.
What are the PE and PB ratios of FORTREA HOLDINGS INC (FTRE) stock?
The Price/Earnings (PE) ratio for FORTREA HOLDINGS INC (FTRE) is 16.87 and the Price/Book (PB) ratio is 1.61.
What is the expected EPS growth for FORTREA HOLDINGS INC (FTRE) stock?
The Earnings per Share (EPS) of FORTREA HOLDINGS INC (FTRE) is expected to grow by 66.4% in the next year.